These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28364694)

  • 1. The role of melatonin, neurokinin, neurotrophic tyrosine kinase and glucocorticoid receptors in antidepressant-like effect.
    Pytka K; Młyniec K; Podkowa K; Podkowa A; Jakubczyk M; Żmudzka E; Lustyk K; Sapa J; Filipek B
    Pharmacol Rep; 2017 Jun; 69(3):546-554. PubMed ID: 28364694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do we need new and better antidepressants?
    Montgomery SA
    Int Clin Psychopharmacol; 2006 Feb; 21 Suppl 1():S1-S10. PubMed ID: 16436933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of melatonin receptor expression in the brain may influence antidepressant treatment.
    Hirsch-Rodriguez E; Imbesi M; Manev R; Uz T; Manev H
    Med Hypotheses; 2007; 69(1):120-4. PubMed ID: 17197111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-124 antagonizes the antidepressant-like effects of standardized gypenosides in mice.
    Yi LT; Mu RH; Dong SQ; Wang SS; Li CF; Geng D; Liu Q
    J Psychopharmacol; 2018 Apr; 32(4):458-468. PubMed ID: 29484897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinone reductase 2 and antidepressant effect of melatonin derivatives.
    Oxenkrug GF; Bachurin SO; Prakhie IV; Zefirov NS
    Ann N Y Acad Sci; 2010 Jun; 1199():121-4. PubMed ID: 20633117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment.
    Wang YQ; Jiang YJ; Zou MS; Liu J; Zhao HQ; Wang YH
    Behav Brain Res; 2022 Feb; 420():113724. PubMed ID: 34929236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.
    Ganjiwale A; Cowsik SM
    Mini Rev Med Chem; 2013 Dec; 13(14):2036-46. PubMed ID: 23937231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF-TrkB Signaling.
    Li K; Shen S; Ji YT; Li XY; Zhang LS; Wang XD
    Neurosci Bull; 2018 Apr; 34(2):303-311. PubMed ID: 29086908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect.
    Pytka K; Dziubina A; Młyniec K; Dziedziczak A; Żmudzka E; Furgała A; Olczyk A; Sapa J; Filipek B
    Pharmacol Rep; 2016 Apr; 68(2):443-50. PubMed ID: 26922551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting glutamate signalling in depression: progress and prospects.
    Murrough JW; Abdallah CG; Mathew SJ
    Nat Rev Drug Discov; 2017 Jul; 16(7):472-486. PubMed ID: 28303025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinins increase [3H]acetylcholine release in mouse striatum through multiple receptor subtypes.
    Preston Z; Lee K; Widdowson L; Richardson PJ; Pinnock RD
    Neuroscience; 2000; 95(2):367-76. PubMed ID: 10658616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
    Schmidt HD; Duman RS
    Behav Pharmacol; 2007 Sep; 18(5-6):391-418. PubMed ID: 17762509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin receptors in the gastrointestinal muscle wall: cell distribution and possible roles.
    Vannucchi MG; Evangelista S
    Biomol Concepts; 2013 Jun; 4(3):221-31. PubMed ID: 25436578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment.
    Calfa G; Kademian S; Ceschin D; Vega G; Rabinovich GA; Volosin M
    Psychoneuroendocrinology; 2003 Jul; 28(5):687-701. PubMed ID: 12727135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P: a pioneer amongst neuropeptides.
    Hökfelt T; Pernow B; Wahren J
    J Intern Med; 2001 Jan; 249(1):27-40. PubMed ID: 11168782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do glutamatergic agents represent a new class of antidepressant drugs? Part 2.
    Sanacora G
    J Clin Psychiatry; 2009 Nov; 70(11):1604-5. PubMed ID: 20031105
    [No Abstract]   [Full Text] [Related]  

  • 19. Emodin opposes chronic unpredictable mild stress induced depressive-like behavior in mice by upregulating the levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor.
    Li M; Fu Q; Li Y; Li S; Xue J; Ma S
    Fitoterapia; 2014 Oct; 98():1-10. PubMed ID: 24932776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-Based Drug Discovery for Novel Antidepressants.
    Pałucha-Poniewiera A; Pilc A
    Expert Opin Drug Discov; 2016 Sep; 11(9):873-83. PubMed ID: 27409299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.